{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:59:58Z","timestamp":1740895198143,"version":"3.38.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":1025,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jsps.2010.07.001","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T10:23:43Z","timestamp":1295432623000},"page":"245-249","source":"Crossref","is-referenced-by-count":3,"title":["Comparative clinical evaluation of ketotifen and montelukast sodium in asthmatic Iraqi patients"],"prefix":"10.1007","volume":"18","author":[{"given":"Fadyia Y.","family":"Al-Hamdani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2010.07.001_b0080","doi-asserted-by":"crossref","unstructured":"American Thoracic Society: Standardization of Spirometry, 1994. Update. Official Statement of American Thoracic Society. Am. J. Respir. Crit. Care Med. 152, 1107\u20131136.","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"10.1016\/j.jsps.2010.07.001_b0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0031-6997(24)01381-4","article-title":"Inflammatory mediators of asthma: an update","volume":"50","author":"Barnes","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.jsps.2010.07.001_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200407-894OC","article-title":"Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma","volume":"171","author":"Bisgaard","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jsps.2010.07.001_b0105","first-page":"61","article-title":"Correlation between symptom score, reversibility of pulmonary function tests and treatment response in asthma","volume":"2","author":"Boskabady","year":"2003","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.jsps.2010.07.001_b0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2222.1995.tb01096.x","article-title":"Prevention of asthma with ketotifen in pre asthmatic children: a three-year follow-up study","volume":"25","author":"Bustos","year":"1995","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0160","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.183.4.1303","article-title":"Central role of immunoglobulin E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production inhibition by a non-anaphylactogenic anti-IgE antibody","volume":"183","author":"Coyle","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/bmj.280.6211.360","article-title":"Ketotifen in adult asthma","volume":"280","author":"Dyson","year":"1980","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jsps.2010.07.001_b0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm.158.1.9705031","article-title":"Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood","volume":"158","author":"Gibson","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jsps.2010.07.001_b0070","first-page":"568","article-title":"Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders","volume":"41","author":"Grant","year":"1992","journal-title":"Adis Drug Inf. Ser."},{"issue":"9","key":"10.1016\/j.jsps.2010.07.001_b0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0165-6147(00)89059-8","article-title":"Cysteinyl leukotrienes in asthma: old mediators up to new tricks","volume":"16","author":"Hay","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jsps.2010.07.001_b0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0165-6147(00)89059-8","article-title":"Cysteinyl leukotrienes in asthma: old mediators up to new tricks","volume":"16","author":"Hay","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.jsps.2010.07.001_b0115","doi-asserted-by":"crossref","first-page":"SII5","DOI":"10.1016\/S0140-6736(97)90029-5","article-title":"The cellular and mediator basis of asthma in relation to natural history","volume":"350","author":"Holgate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2010.07.001_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-3038.2005.00273.x","article-title":"Discrepant clinical responses and blood chemokine profiles between non-steroid anti-inflammatory medications for children with mild persistent asthma","volume":"16","author":"Hung","year":"2005","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.jsps.2010.07.001_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.1992.tb14204.x","article-title":"Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways","volume":"105","author":"Iwama","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsps.2010.07.001_b0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1081-1206(10)62433-7","article-title":"Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo-controlled trial","volume":"85","author":"Kabra","year":"2000","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jsps.2010.07.001_b0135","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-200363100-00005","article-title":"Pranlukast: a review of its use in the management of asthma","volume":"63","author":"Keam","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jsps.2010.07.001_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-2002-34333","article-title":"Leukotriene receptor antagonists","volume":"23","author":"Krawiec","year":"2002","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2222.1980.tb02132.x","article-title":"A steroid sparing effect of ketotifen in steroid-dependent asthmatics","volume":"10","author":"Lane","year":"1980","journal-title":"Clin. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.53.082901.103921","article-title":"The pathophysiology of asthma","volume":"53","author":"Maddox","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0021-8707(66)90036-0","article-title":"Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma","volume":"38","author":"Makino","year":"1966","journal-title":"J. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0155","first-page":"145","article-title":"Ketotifen: a histamine release inhibitor","volume":"12","author":"Martin","year":"1977","journal-title":"Monogr. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2222.2003.01696.x","article-title":"Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites","volume":"33","author":"Mechiche","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0110","unstructured":"Global strategy for asthma management and prevention workshop report, 2002. Bethesda, National Heart, Lung, and Blood Institute (National Institutes of Health) 02, p. 3659."},{"key":"10.1016\/j.jsps.2010.07.001_b0100","unstructured":"National Institutes of Health, 2002. Global strategy for asthma management and prevention, In NHBLI workshop report, Bethesda, MD, January 02, p. 3659."},{"issue":"6","key":"10.1016\/j.jsps.2010.07.001_b0120","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.160.6.9903114","article-title":"Induced sputum eicosanoid concentrations in asthma","volume":"160","author":"Pavord","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0091-6749(89)90410-7","article-title":"A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years","volume":"84","author":"Rackham","year":"1989","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl.","key":"10.1016\/j.jsps.2010.07.001_b0095","first-page":"289S","article-title":"MK-0476, an LTD4 receptor antagonist, exhibits a dose-related improvement in the once daily treatment of patients with chronic asthma","volume":"19","author":"Reiss","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jsps.2010.07.001_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/thx.52.1.45","article-title":"Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids","volume":"52","author":"Reiss","year":"1997","journal-title":"Thorax"},{"issue":"Suppl. 25","key":"10.1016\/j.jsps.2010.07.001_b0085","first-page":"437S","article-title":"Montelukast (MK-0476), a CysLT 1 receptor antagonist, improves the signs and symptoms of asthma over one year of treatment","volume":"10","author":"Reiss","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jsps.2010.07.001_b0090","first-page":"A662","article-title":"Montelukast (MK-0476), a CysLT 1 receptor antagonist, improves asthma outcomes over a 3-month treatment period","volume":"155","author":"Reiss","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","article-title":"Montelukast, a once daily leukotriene receptor antagonist in the treatment of chronic asthma: a multicenter, randomized, double-blind trial","volume":"158","author":"Reiss","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsps.2010.07.001_b0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1365-2222.1999.00667.x","article-title":"Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing","volume":"29","author":"Shield","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jsps.2010.07.001_b0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1203\/01.PDR.0000072328.28105.06","article-title":"A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma","volume":"54","author":"Strauch","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsps.2010.07.001_b0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0091-6749(99)70322-2","article-title":"Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukust\/Salmeterol Exercise Study Group","volume":"104","author":"Villaran","year":"1999","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016410000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016410000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T22:50:20Z","timestamp":1740869420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016410000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1319016410000642"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2010.07.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"type":"print","value":"1319-0164"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}